This Article Full Text Full Text (PDF) All Versions of this Article: 108/7/814    most recent 01.CIR.0000084553.92734.83v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barrabés, J. A. Articles by Soler-Soler, J. Search for Related Content PubMed PubMed Citation Articles by Barrabés, J. A. Articles by Soler-Soler, J. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Heart Attack Related Collections Acute coronary syndromes Acute myocardial infarction Electrocardiology

(Circulation. 2003;108:814.)
© 2003 American Heart Association, Inc.

Clinical Investigation and Reports

Prognostic Value of Lead aVR in Patients With a First Non–ST-Segment Elevation Acute Myocardial Infarction

José A. Barrabés, MD; Jaume Figueras, MD; Cristina Moure, MD; Josefa Cortadellas, MD; Jordi Soler-Soler, MD

From Unitat Coronària, Servicio de Cardiología, Hospital Universitari Vall d’Hebron, Barcelona, Spain.

Correspondence to José A. Barrabés, MD, Unitat Coronària, Servicio de Cardiología, Hospital Universitari Vall d’Hebron, Pg Vall d’Hebron 119-129, 08035 Barcelona, Spain. E-mail jabarrab{at}vhebron.net

Received January 17, 2003; de novo received May 6, 2003; accepted May 15, 2003.

Background— ST-segment elevation in lead aVR has been associated with severe coronary artery lesions in patients with acute coronary syndromes, but the prognostic significance of this finding is unknown.

Methods and Results— We analyzed the initial ECG in 775 consecutive patients admitted to our center with a first acute myocardial infarction without ST-segment elevation in leads other than aVR or V₁. The rates of in-hospital death in patients without (n=525) and with 0.05 to 0.1 mV (n=116) or 0.1 mV (n=134) of ST-segment elevation in lead aVR were 1.3%, 8.6%, and 19.4%, respectively (P<0.001). After adjustment for the baseline clinical predictors and for ST-segment depression on admission, the odds ratios for death in the last 2 groups were, respectively, 4.2 (95% CI, 1.5 to 12.2) and 6.6 (95% CI, 2.5 to 17.6). The rates of recurrent ischemic events and heart failure during hospital stay also increased in a stepwise fashion among the groups, whereas creatine kinase–MB levels were similar. Among the 437 patients that were catheterized within 6 months, the prevalence of left main or 3-vessel coronary artery disease in the 3 groups was 22.0%, 42.6%, and 66.3%, respectively (P<0.001).

Conclusions— Lead aVR contains important short-term prognostic information in patients with a first non–ST-segment elevation acute myocardial infarction. Because the poorer outcome predicted by ST-segment elevation in lead aVR seems to be related to a more severe coronary artery disease, an early invasive approach might be especially beneficial in patients presenting with this finding.

Key Words: myocardial infarction • electrocardiography • prognosis • mortality

This article has been cited by other articles:

				S. P. Schulman Electrocardiographic Findings in Non-ST-Segment Elevation Myocardial Infarction--Reply JAMA, January 26, 2005; 293(4): 423 - 424. [Full Text] [PDF]

				S. P. Schulman Antiplatelet Therapy in Non-ST-Segment Elevation Acute Coronary Syndromes JAMA, October 20, 2004; 292(15): 1875 - 1882. [Abstract] [Full Text] [PDF]

				W. W. O'Neill and S. R. Dixon The year in interventional cardiology J. Am. Coll. Cardiol., March 3, 2004; 43(5): 875 - 890. [Full Text] [PDF]